4.6 Article

Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality by Stage and Histologic Subtype

Related references

Note: Only part of the references are listed.
Article Oncology

Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment

Alicia Leon-Castillo et al.

Summary: The study evaluates the clinical outcome of molecular subgroups in high-grade endometrial cancer (EC) patients staged with lymphadenectomy and those without adjuvant treatment. The molecular classification has strong prognostic value, independent of clinicopathological factors. The unfavorable prognosis of early-stage p53abn EC is not due to undetected lymph node metastasis, and the indolent behavior of POLEmut EC is independent of adjuvant treatment.

GYNECOLOGIC ONCOLOGY (2022)

Article Oncology

Adjuvant chemotherapy and radiation for patients with high-risk stage I endometrial cancer treated with curative intent surgery: impact on recurrence and survival

Rachelle Findley et al.

Summary: For patients with high-risk stage I endometrial cancer, post-operative chemotherapy or radiation therapy does not significantly improve cancer-specific or overall survival. Patients who received four cycles or fewer of chemotherapy had similar survival outcomes compared to those who received five to six cycles.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

Review Oncology

Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy

Anne Sophie V. M. van den Heerik et al.

Summary: Endometrial cancer is primarily treated with surgery, with adjuvant treatments such as radiotherapy and chemotherapy being considered based on clinico-pathological risk factors. Recent studies have shown the effectiveness of different treatment strategies for different risk levels of endometrial cancer, highlighting the importance of personalized treatment approaches. Molecular classification and targeted treatments are emerging as potential advancements in the field, with ongoing trials exploring their impact on patient outcomes.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

Article Medicine, General & Internal

Estimated Projection of US Cancer Incidence and Death to 2040

Lola Rahib et al.

Summary: This cross-sectional study projected cancer incidences and deaths in the United States up to 2040. The findings indicate significant changes in the most common cancers by 2040, with breast cancer projected to become the most common cancer and lung cancer remaining the leading cause of cancer-related death.

JAMA NETWORK OPEN (2021)

Article Obstetrics & Gynecology

Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment

Mara Kaspers et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2020)

Review Medicine, General & Internal

Endometrial Cancer

Karen H. Lu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Obstetrics & Gynecology

Endometrial cancer disparities: a race-conscious critique of the literature

Kemi M. Doll et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)

Article Oncology

Untitled

INTERNATIONAL JOURNAL OF CANCER (2018)

Article Obstetrics & Gynecology

Receipt of adjuvant endometrial cancer treatment updates according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study

Ashley S. Felix et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)

Article Public, Environmental & Occupational Health

Uterine Cancer Incidence and Mortality — United States, 1999–2016

S. Jane Henley et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)

Article Oncology

Bokhman Redux: Endometrial cancer types in the 21st century

Adrian A. Suarez et al.

GYNECOLOGIC ONCOLOGY (2017)

Article Oncology

The Hispanic Paradox in endometrial cancer: A National Cancer Database study

Erica M. Malagon-Blackwell et al.

GYNECOLOGIC ONCOLOGY (2017)

Article Oncology

The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women

Michele L. Cote et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)

Article Oncology

Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites

Linda S. Cook et al.

CANCER CAUSES & CONTROL (2013)

Article Oncology

The impact of race on outcomes of patients with early stage uterine endometrioid carcinoma

Mohamed A. Elshaikh et al.

GYNECOLOGIC ONCOLOGY (2013)

Article Oncology

Type I and II Endometrial Cancers: Have They Different Risk Factors?

Veronica Wendy Setiawan et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Article Obstetrics & Gynecology

Improved survival of Asians with corpus cancer compared with whites - An analysis of underlying factors

Mallory M. Zhang et al.

OBSTETRICS AND GYNECOLOGY (2006)